Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Mouwasat Medical Services Co Buyback Yield % Chart
SAU:4002 vs HCA, THC, DVA: Buyback Yield % Comparison
For the Medical Care Facilities subindustry, Mouwasat Medical Services Co's Buyback Yield %, along with its competitors' market caps and Buyback Yield % data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Mouwasat Medical Services Co Buyback Yield % vs Healthcare Providers & Services Industry
For the Healthcare Providers & Services industry and Healthcare sector, Mouwasat Medical Services Co's Buyback Yield % distribution charts can be found below:
* The bar in red indicates where Mouwasat Medical Services Co's Buyback Yield % falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Mouwasat Medical Services Co (SAU:4002) has a Buyback Yield % of 0.00 as of Jul. 22, 2026. Share buyback yield equals the net issuance of stock divided by market cap. View historical data on Mouwasat Medical Services Co and its competitors. According to the industry distribution chart, Mouwasat Medical Services Co ranks #999999 out of 275 companies in the Healthcare Providers & Services industry.
Is Mouwasat Medical Services Co's Buyback Yield % too high?
Mouwasat Medical Services Co's current Buyback Yield % is 0.00. Based on the distribution chart, Mouwasat Medical Services Co ranks #999999 out of 275 companies in the Healthcare Providers & Services industry, which is in the bottom quartile relative to peers. Overall, Mouwasat Medical Services Co has a GF Score™ of 100/100 and is considered Significantly Undervalued, reflecting its overall financial health beyond just this single metric.
How does Mouwasat Medical Services Co's Buyback Yield % compare to HCA and THC?
According to the Healthcare Providers & Services industry distribution chart, Mouwasat Medical Services Co ranks #999999 out of 275 companies for Buyback Yield %. This places Mouwasat Medical Services Co in the lower half of its industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Buyback Yield % for a Healthcare Providers & Services company?
A good Buyback Yield % depends on the Healthcare Providers & Services industry context. However, Buyback Yield % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Buyback Yield % mean?
A high Buyback Yield % can signal that a stock is expensive relative to its fundamentals. Share buyback yield equals the net issuance of stock divided by market cap. View historical data on Mouwasat Medical Services Co and its competitors. Mouwasat Medical Services Co's current Buyback Yield % is 0.00. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Mouwasat Medical Services Co stock overvalued right now?
Based on GuruFocus' analysis, Mouwasat Medical Services Co (SAU:4002) is currently considered Significantly Undervalued. The stock's GF Value™ is ﷼109.66, compared to a current price of ﷼60.00 — trading 45.3% below its estimated fair value. The current Buyback Yield % is 0.00. Mouwasat Medical Services Co's overall GF Score™ is 100/100 with 5 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Buyback Yield % calculated?
Buyback Yield % is calculated from a company's financial statements. For Mouwasat Medical Services Co (SAU:4002), the current Buyback Yield % is 0.00 as of Jul. 22, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Mouwasat Medical Services Co (SAU:4002) Overvalued in 2026?
Based on GuruFocus' analysis, Mouwasat Medical Services Co stock appears to be undervalued.
The current stock price of ﷼60.00 is trading 45.3% below its estimated GF Value™ of ﷼109.66.
GuruFocus considers Mouwasat Medical Services Co to be Significantly Undervalued.
Key valuation signals for SAU:4002:
Buyback Yield %: 0.00
GF Value™: ﷼109.66 vs. price of ﷼60.00 (45.3% below fair value)
No single metric tells the full story. See the SAU:4002 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Mouwasat Medical Services Co is engaged in the acquisition, management, operation, and maintenance of hospitals, medical centers, drug stores, pharmacies, and wholesale of medical equipment and drugs. The company also operates skin care centers that offer clinical and cosmetic dermatology, aesthetic and reconstructive plastic surgery, weight reduction, and esthetician services. It operates in two segments Medical Services segment and Pharmaceuticals out of which the Medical Services segment derives the majority of revenue. The Medical Services segment includes Inpatient and outpatient services. The company provides specialized centers: Eye Center, Robotic Surgeries Center, Diabetes Center, Fertility Unit, Cardiology Center, Stroke Unit, Long Term Care Center, Obesity Center, and others.
100GF Score
Get the complete analysis for SAU:4002
Buyback Yield % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
SAU:4002 has been successfully added to your 
